Healthcare · Healthcare Services
QVM read Weak on all three Quality Weak, Valuation Expensive, Momentum Bearish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #19 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 10 Mar 2026 | Jasti Property and Equity Holdings Private Limited | Promoter group | Buy | 0 | ₹0 |
| 7 Jul 2025 | Jasti Property and Equity Holdings Private Limited | Promoter group | Buy | 0 | ₹0 |
| 29 May 2024 | SUDHARANI JASTI | Promoter group | Buy | 0 | ₹0 |
| 29 Mar 2022 | Jasti Property and Equity Holdings Private Limited | Promoter group | Buy | 0 | ₹0 |
| 6 Apr 2021 | Jasti Property and Equity Holdings Private Limited | Promoter group | Buy | 0 | ₹0 |
| 2 Sep 2020 | VENKATA RAMUDU JASTHI | Immediate relative | Buy | 0 | ₹0 |
| 31 Aug 2020 | VENKATA RAMUDU JASTHI | Immediate relative | Buy | 0 | ₹0 |
| 27 Aug 2020 | VENKATA RAMUDU JASTHI | Immediate relative | Buy | 0 | ₹0 |
| 24 Aug 2020 | VENKATA RAMUDU JASTHI | Immediate relative | Buy | 0 | ₹0 |
| 31 Mar 2016 | JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED | Promoter | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 13 Sep 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 1,534,944 | 78.2000 | NSE |
| 13 Sep 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 1,534,944 | 78.1200 | NSE |
| 23 Apr 2021 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 640,960 | 109.9700 | NSE |
| 23 Apr 2021 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 640,960 | 109.6400 | NSE |
| 17 Dec 2020 | ALPHA LEON ENTERPRISES LLP | Bulk | Buy | 656,474 | 104.9400 | NSE |
| 17 Dec 2020 | ALPHA LEON ENTERPRISES LLP | Bulk | Sell | 627,462 | 105.0800 | NSE |
| 18 Sep 2020 | KATKAR SANJAY | Bulk | Buy | 688,893 | 56.2700 | NSE |
| 21 Apr 2020 | ALPHA LEON ENTERPRISES LLP | Bulk | Sell | 761,598 | 32.1700 | NSE |
| 21 Apr 2020 | ALPHA LEON ENTERPRISES LLP | Bulk | Buy | 750,015 | 29.7500 | NSE |
| 26 Mar 2020 | ALPHA LEON ENTERPRISES LLP | Bulk | Buy | 744,288 | 24.8600 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 14 Feb 2019 | Interim Dividend - Rs 1.50 Per Share | 1.5000 | 15 Feb 2019 |
| 6 Feb 2018 | Interim Dividend - Rs 1.50 Per Share (Purpose Revised) | 1.5000 | 7 Feb 2018 |
| 8 Feb 2017 | Interim Dividend Re 1 Per Share | 1.0000 | 9 Feb 2017 |
| 14 Mar 2016 | Interim Dividend - Re 1/- Per Share / Special Dividend - Re 1/- Per Share (Purpose Revised) | 1.0000 | 15 Mar 2016 |
| 23 Jul 2015 | Annual General Meeting/Dividend - Re 0.60/- Per Share | 0.6000 | — |
| 24 Jul 2014 | Annual General Meeting /Final Dividend - Re 0.50/- Per Share + Special Dividend - Rs 2/- Per Share | 0.5000 | — |
| 1 Aug 2013 | Annual General Meeting / Dividend - Re.0.30/- Per Equity Share | 0.3000 | — |
| 17 Sep 2012 | Annual General Meeting And Dividend Re.0.30 Per Share | 0.3000 | — |
| 1 Aug 2011 | Annual General Meeting And Dividend Re.0.25 Per Share | 0.2500 | — |
| 11 Sep 2008 | Agm/Dividend - 25% | — | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Suven Pharmaceuticals Ltd. to Suven Life Sciences Ltd. |
| 30 Jul 2024 | OTHER | Annual General Meeting |
| 2 Aug 2023 | OTHER | Annual General Meeting |
| 17 Oct 2022 | RIGHTS | Rights 1:2 @ Premium Rs 54/- |
| 29 Jul 2022 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 6 Aug 2026 | Financial Results | Yes |
| 29 Jan 2026 | Financial Results | Yes |
| 11 Nov 2025 | Financial Results | Yes |
| 13 Aug 2025 | Financial Results | Yes |
| 13 May 2025 | Financial Results/Fund Raising | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
